Refine results by
Top countries
Publication dates
All countries
Popular tags
91-120 of 6 467 Premium Reports from 56 Publishers
Datamonitor's Generics in Europe industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and ...
Industries : Generic Drug
Datamonitor's Generics in France industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and ...
Industries : Generic Drug
Datamonitor's Generics in Germany industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies an ...
Industries : Generic Drug
Datamonitor's Generics in Italy industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and ...
Industries : Generic Drug
Datamonitor's Generics in Japan industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and ...
Industries : Generic Drug
Datamonitor's Generics in Spain industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and ...
Industries : Generic Drug
Datamonitor's Generics in the Netherlands industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading comp ...
Industries : Generic Drug
Datamonitor's Generics in the United Kingdom industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading c ...
Industries : Generic Drug
Datamonitor's Generics in the United States industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading co ...
Industries : Generic Drug
BMI?s drug forecast for Vietnam has been affected in recent months by negative macroeconomic factors.Vietnam, like many of Asia?s export-focused manufacturing economies, is vulnerable to a downturn inWestern markets in which much of its output is consumed. This has a knock on effect on employment an ...
Industries : Healthcare, Pharmaceutical
Despite the Italian pharmaceuticals market being the sixth largest globally, its potential for expansionlooks to be limited based on recent trends, including the contraction of the prescription market. The totalmarket contracted in both 2007 and 2008, when it reached EUR18.87bn (US$27.75bn). The ma ...
Industries : Healthcare, Pharmaceutical
BMI calculates the Netherlands?s pharmaceutical expenditure to have been EUR5.8bn (US$8.5bn) in2008. By 2013, we expect the total amount spent on prescription and OTC medicines to have reachedEUR6.6bn, equating to a compound annual growth rate (CAGR) of 2.7%.Looking forward, BMI?s new 10-year foreca ...
Industries : Healthcare, Pharmaceutical
Puerto Rico?s pharmaceutical market is showing sizeable growth in nominal terms (11.6% year-on-year(y-o-y) in 2009), but high inflation in the economy will erode many of these gains. BMI expects thePuerto Rican drug market to increase from US$2.9bn in 2008 to US$4.086bn by 2013, representing acompou ...
Industries : Healthcare, Pharmaceutical
In BMI?s Business Environment Rankings (BER) for Q409, Israel once again slipped down the table ofthe 17 Middle East and African (MEA) markets surveyed, now ranking 11th. Despite the country?swealthy and urbanised population, its regulatory environment, falling state contribution to healthcare andpo ...
Industries : Healthcare, Pharmaceutical
In BMI?s updated Business Environment Rankings (BER), Saudi Arabia is ranked second, out of the 17Middle East and African (MEA) markets surveyed. The country?s score is propped up by its sizeable andwealthy population as well as a steady forecast annual growth of its drug expenditure. Over the forec ...
Industries : Healthcare, Pharmaceutical
The clinical trial market in India looks very lucrative. The country promises to be one of the hottest destinations for conducting global clinical trials, owing to a huge patient pool representing both chronic and infectious diseases, easy recruitment of patients, and high cost savings. Moreover, th ...
Industries : Pharmaceutical | Countries : India
THIS REPORT WILL:Provide a detailed analysis of the excipients market today and a forecast of what the market will look like in 5 yearsOffer information on inert ingredients, the types of technologies used to make them, their uses, and regulatory influences Highlight excipients by chemical compounds ...
Industries : Pharmaceutical
According to BMI?s Asia Pacific Pharmaceuticals & Healthcare Business Environment Ranking table forQ409, Hong Kong?s pharmaceutical market slipped from being the fifth-most attractive in the region to ajoint sixth. Globally, Hong Kong places joint 25th out of the 71 countries surveyed by BMI. Althou ...
Industries : Healthcare, Pharmaceutical
The Q409 update of BMI?s Philippines Pharmaceuticals & Healthcare report contains for the first time a10-year forecast for medicine expenditure. The US$2.61bn market is forecast to experience slight growthof 1.8% in 2009. This is mainly due to local currency depreciation, but also a deterioratingmac ...
Industries : Healthcare, Pharmaceutical
In BMI?s Business Environment Rankings (BER) for Q409, Belgium rose by one place to 7th position inthe regional matrix, out of the 9 countries surveyed in Western Europe. While its advanced status, ageingpopulation and high per-capita income should support market development going forwards, annualg ...
Industries : Healthcare, Pharmaceutical
Bulgaria?s pharmaceutical market has transformed from the low-value, low-growth market of just a fewyears ago to one of the fastest-growing in Central and Eastern Europe (CEE). EU accession has helpedboost sales of higher value products, while regulatory developments have added greater transparency ...
Industries : Healthcare, Pharmaceutical
BMI calculates Germany?s pharmaceutical expenditure to have been EUR37.3bn (US$55.0bn) in 2008.By 2013, we expect the total amount spent on prescription and OTC medicines to have reached a value ofEUR41.7bn, equating to a compound annual growth rate (CAGR) of 3.7% in local currency terms.However, d ...
Industries : Healthcare, Pharmaceutical
Qatar is now ranked third out of 17 countries in the Middle East and Africa (MEA) region in BMI?s Q409Business Environment Rankings (BER), slipping from second in the previous quarter. While Qatar offersa favourable market and country structure, including a predictable operating environment and a so ...
Industries : Healthcare, Pharmaceutical
We expect the total drug market to increase in value from US$2.17bn in 2008 to US$3.21bn by 2013,representing a compound annual growth rate (CAGR) of 8.2% in US dollar terms. Pharmaceuticalspending will comprise 0.65% of GDP, and US$41.60 per capita spending by 2013. We believe thatgrowth will be d ...
Industries : Healthcare, Pharmaceutical
Report DescriptionThe global market for neurostimulation products is expected to be worth $3.6 billion in 2009, growing at a CAGR of 22.7%, driven by the multiple treatment applications of neurostimulation products, and the emergence of venture capital in the industry.Neurostimulation is used for th ...
Industries : Therapy
INDUSTRY MARKET RESEARCH REPORTThis is the replacement for March 2009 edition of Physical Therapists in the US report.Industry Market Research SynopsisThis Industry Market Research report provides a detailed analysis of the Physical Therapists in the US industry, including key growth trends, statis ...
Industries : Therapy
The Middle East and Africa pharmaceutical industry is entering a new era, with the development of infrastructure system and rapidly changing regulations. The industry is blessed with several advantages like high prevalence of diseases, huge population base and many more, reflecting bight prospects o ...
Industries : Pharmaceutical
Parallel trade is a legitimate method of pharmaceutical import and export within the EU zone. Although previously recognized in North America as illegal, cross-border reimportation is now permitted following legislation allowing drugs to be imported into the US from Canada. However, counterfeit drug ...
Industries : Pharmaceutical
The Middle East pharmaceutical market is diverse, with a significant presence of leading global players alongside domestic pharmaceutical companies such as Ibrahim, Bilim and Deva. The market dynamics are further shaped by the presence of several leading suppliers of branded generics and APIs (activ ...
Industries : Pharmaceutical
Euromonitor International's Analgesics in Mexico report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading ...
Industries : Generic Drug
reportlinker.com © Copyright 2009. All rights reserved